Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 19952951 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | negation | |
| allogeneic stem cell transplantation (sct) from cord blood (cb) as a stem cell source is a promising alternative when no human leukocyte antigen-matched donor is found. | |||||||
| 19952955 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| soluble recombinant cmvpp65 spanning multiple hla alleles for reconstitution of antiviral cd4+ and cd8+ t-cell responses after allogeneic stem cell transplantation. | |||||||
| 19962170 | HLA-DR (HLA-DR) | stem cell transplantation | NA | NA | NA | unclassified | |
| ex vivo detection of adenovirus specific cd4+ t-cell responses to hla-dr-epitopes of the hexon protein show a contracted specificity of t(helper) cells following stem cell transplantation. | |||||||
| 20009439 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | negative | |
| she underwent reduced-intensity stem cell transplantation (rist) from an hla-identical sibling donor. | |||||||
| 20134143 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | busulfan | NA | unclassified | |
| he received a preparative regimen including busulfan followed by allo-peripheral blood stem cell transplantation from an hla-matched sibling donor. | |||||||
| 20154501 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | melphalan | NA | negative | |
| he received reduced-intensity stem cell transplantation (rist)from an hla-identical unrelated donor. | |||||||
| 20188202 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| natural killer cell-enriched donor lymphocyte infusions from a 3-6/6 hla matched family member following nonmyeloablative allogeneic stem cell transplantation. | |||||||
| 20348971 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| patients (age range 13-68 years) had developed acute gvhd grade iii and iv with gut and/or liver involvement after stem cell transplantation from family donors (n= 7) or hla-matched unrelated donors (n=11), including five donors with one or two hla mismatches. | |||||||
| 20382088 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| cord blood units (cbus) are increasingly being used for unrelated allogeneic stem cell transplantation and their selection is mainly done according to pre-freezing cell dose and hla donor/recipient compatibility. | |||||||
| 20476937 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| the development of this new therapeutic modality has been driven by the established morbidity and mortality associated with conventional allogeneic stem cell transplantation, particularly in the human leukocyte antigen-mismatched setting. | |||||||
Copyright 2024